91 related articles for article (PubMed ID: 15177924)
1. Interaction of ovokinin(2-7) with vascular bradykinin 2 receptors.
Scruggs P; Filipeanu CM; Yang J; Chang JK; Dun NJ
Regul Pept; 2004 Aug; 120(1-3):85-91. PubMed ID: 15177924
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of non-capacitative Ca2+ influx in response to bradykinin in vascular endothelial cells.
Leung PC; Cheng KT; Liu C; Cheung WT; Kwan HY; Lau KL; Huang Y; Yao X
J Vasc Res; 2006; 43(4):367-76. PubMed ID: 16791008
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of ovokinin, a bradykinin B1 agonist peptide derived from ovalbumin.
Fujita H; Usui H; Kurahashi K; Yoshikawa M
Peptides; 1995; 16(5):785-90. PubMed ID: 7479316
[TBL] [Abstract][Full Text] [Related]
4. Kinin-B1 receptors in ischaemia-induced pancreatitis: functional importance and cellular localisation.
Kuebler JF; Schremmer-Danninger E; Bhoola KD; Roscher AA; Messmer K; Hoffmann TF
Biol Chem; 2003 Sep; 384(9):1311-9. PubMed ID: 14515994
[TBL] [Abstract][Full Text] [Related]
5. Vascular B1 kinin receptors in patients with congestive heart failure.
Lang NN; Cruden NL; Tse GH; Bloomfield P; Ludlam CA; Fox KA; Newby DE
J Cardiovasc Pharmacol; 2008 Nov; 52(5):438-44. PubMed ID: 19033823
[TBL] [Abstract][Full Text] [Related]
6. Expression and functional pharmacology of the bradykinin B1 receptor in the normal and inflamed human gallbladder.
Andre E; Gazzieri D; Bardella E; Ferreira J; Mori MA; Saul VV; Bader M; Calixto JB; De Giorgio R; Corinaldesi R; Geppetti P; Trevisani M
Gut; 2008 May; 57(5):628-33. PubMed ID: 18182589
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin-induced IL-6 expression through bradykinin B2 receptor, phospholipase C, protein kinase Cdelta and NF-kappaB pathway in human synovial fibroblasts.
Lee CH; Shieh DC; Tzeng CY; Chen CP; Wang SP; Chiu YC; Huang CY; Hsu CJ; Fong YC; Tang CH
Mol Immunol; 2008 Aug; 45(14):3693-702. PubMed ID: 18621420
[TBL] [Abstract][Full Text] [Related]
9. BK2 but not BK1 receptors mediating contractile response in human umbilical arteries: role of thromboxane A2.
Tiritilli A; El Habach T; Haury L; Duret JF
Methods Find Exp Clin Pharmacol; 2004 May; 26(4):247-52. PubMed ID: 15319801
[TBL] [Abstract][Full Text] [Related]
10. Activation of osteoblastic functions by a mediator of pain, bradykinin.
Kondo A; Togari A
Biochem Pharmacol; 2004 Oct; 68(7):1423-31. PubMed ID: 15345332
[TBL] [Abstract][Full Text] [Related]
11. The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors.
Bawolak MT; Fortin JP; Vogel LK; Adam A; Marceau F
Eur J Pharmacol; 2006 Dec; 551(1-3):108-11. PubMed ID: 17026984
[TBL] [Abstract][Full Text] [Related]
12. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
Morissette G; Bouthillier J; Marceau F
Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin regulates calpain and proinflammatory signaling through TRPM7-sensitive pathways in vascular smooth muscle cells.
Yogi A; Callera GE; Tostes R; Touyz RM
Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R201-7. PubMed ID: 18799634
[TBL] [Abstract][Full Text] [Related]
14. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
[TBL] [Abstract][Full Text] [Related]
15. MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs.
Valenti C; Cialdai C; Giuliani S; Lecci A; Tramontana M; Meini S; Quartara L; Maggi CA
J Pharmacol Exp Ther; 2005 Nov; 315(2):616-23. PubMed ID: 16027229
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP increases bradykinin receptor binding affinity in human endothelial cells.
Stewen P; Outi S; Tuulikki N; Frej F
Life Sci; 2004 Apr; 74(23):2839-52. PubMed ID: 15050422
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and functional characterization of bradykinin B2 receptor in human prostate.
Srinivasan D; Kosaka AH; Daniels DV; Ford AP; Bhattacharya A
Eur J Pharmacol; 2004 Nov; 504(3):155-67. PubMed ID: 15541417
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of nicotinic currents by bradykinin in the paratracheal ganglia neurons of rats.
Rong Zhou J; Shirasaki T; Soeda F; Takahama K
Eur J Pharmacol; 2006 Feb; 531(1-3):96-102. PubMed ID: 16442093
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of cardioprotection against ischemia/reperfusion injury by valsartan: an experiment with isolated rat hearts].
Zhang YJ; Bai XJ; Qi ZM; Wang HX
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3350-3. PubMed ID: 16409843
[TBL] [Abstract][Full Text] [Related]
20. Receptor mediation and nociceptin inhibition of bradykinin-induced plasma extravasation in the knee joint of the rat.
Moriyama K; Liu J; Jang Y; Chae YJ; Wang Y; Mitchell J; Grond S; Han X; Xing Y; Xie GX; Pierce Palmer P
Inflamm Res; 2009 Dec; 58(12):873-80. PubMed ID: 19544046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
